Puneeta Tandon

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. doi request reprint The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis
    Puneeta Tandon
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Gastroenterol 108:1473-9. 2013
  2. doi request reprint Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value
    Puneeta Tandon
    Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Alberta, Canada
    Liver Transpl 18:1209-16. 2012
  3. doi request reprint The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Int 29:169-74. 2009
  4. doi request reprint Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Liver Int 29:1110-5. 2009
  5. ncbi request reprint Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials
    P Tandon
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 25:1017-28. 2007
  6. ncbi request reprint A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, Canada
    Am J Gastroenterol 104:1700-6. 2009
  7. pmc The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience
    Karli J Moncrief
    University of Alberta, Edmonton, Canada
    Can J Gastroenterol 24:40-6. 2010
  8. ncbi request reprint VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis
    Saumya Jayakumar
    Department of Medicine, University of Calgary, Calgary, Alberta, Canada Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Int 33:1470-7. 2013
  9. doi request reprint Risk factors for recurrence of autoimmune hepatitis after liver transplantation
    Aldo J Montano-Loza
    Division of Gastroenterology and Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada
    Liver Transpl 15:1254-61. 2009
  10. doi request reprint Alcohol use while on the liver transplant waiting list: a single-center experience
    Michelle Carbonneau
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Transpl 16:91-7. 2010

Collaborators

Detail Information

Publications22

  1. doi request reprint The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis
    Puneeta Tandon
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Gastroenterol 108:1473-9. 2013
    ..We aimed therefore to develop and validate a model for the prediction of 30-day mortality in SBP patients receiving standard medical treatment (antibiotics and if indicated by guidelines, intravenous albumin therapy)...
  2. doi request reprint Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value
    Puneeta Tandon
    Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Alberta, Canada
    Liver Transpl 18:1209-16. 2012
    ..If this is validated in larger studies, the objective assessment of sarcopenia holds promise for prognostication in this patient population...
  3. doi request reprint The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Int 29:169-74. 2009
    ....
  4. doi request reprint Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Liver Int 29:1110-5. 2009
    ..The objective of this study was to determine whether the probiotic VSL#3 would reduce portal pressure in patients with cirrhosis...
  5. ncbi request reprint Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials
    P Tandon
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 25:1017-28. 2007
    ..Although reversal of pretransplant renal dysfunction in hepatorenal syndrome reduces post-transplant complications, the overall impact on morbidity and mortality requires clarification...
  6. ncbi request reprint A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, Canada
    Am J Gastroenterol 104:1700-6. 2009
    ....
  7. pmc The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience
    Karli J Moncrief
    University of Alberta, Edmonton, Canada
    Can J Gastroenterol 24:40-6. 2010
    ..To describe the natural history of primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) after liver transplant, the predictors of PSC and IBD recurrence, and the interaction of these disease processes...
  8. ncbi request reprint VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis
    Saumya Jayakumar
    Department of Medicine, University of Calgary, Calgary, Alberta, Canada Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Int 33:1470-7. 2013
    ..The primary objective of this randomized, double blind placebo controlled trial was to evaluate the effect of the probiotic VSL#3(®) on the hepatic venous pressure gradient (HVPG)...
  9. doi request reprint Risk factors for recurrence of autoimmune hepatitis after liver transplantation
    Aldo J Montano-Loza
    Division of Gastroenterology and Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada
    Liver Transpl 15:1254-61. 2009
    ..These findings suggest that recurrence of autoimmune hepatitis may reflect incomplete suppression of disease activity prior to liver transplantation...
  10. doi request reprint Alcohol use while on the liver transplant waiting list: a single-center experience
    Michelle Carbonneau
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Transpl 16:91-7. 2010
    ..We hope that these measures will reduce the rate of relapse to alcohol use post-transplantation...
  11. ncbi request reprint Asymptomatic bacteriuria is an independent predictor of urinary tract infections in an ambulatory cirrhotic population: a prospective evaluation
    Carrie Ye
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Liver Int 34:e39-44. 2014
    ..We undertook this study to determine the prevalence and incidence of ASB in an outpatient population and its association with UTI...
  12. pmc High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center
    Puneeta Tandon
    University of Alberta, Edmonton, Alberta, Canada
    Clin Gastroenterol Hepatol 10:1291-8. 2012
    ..Exposure to systemic antibiotics is a risk factor for AR-BI; however, little is known about the effects of the increasingly used oral nonabsorbed antibiotics...
  13. pmc Cardiac work-up protocol for liver transplant candidates: experience from a single liver transplant centre
    Carrie Ye
    Liver Unit, Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2X8, Canada
    Can J Gastroenterol 26:806-10. 2012
    ..Ischemic cardiac events can cause significant morbidity and mortality postliver transplantation; however, no validated protocols to screen patients before transplantation exist...
  14. ncbi request reprint Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation
    Aldo J Montano-Loza
    Division of Gastroenterology, University of Alberta Hospital, Edmonton, Canada Liver Unit, University of Alberta Hospital, Edmonton, Canada
    Liver Transpl 20:640-8. 2014
    ....
  15. doi request reprint Bacterial infections, sepsis, and multiorgan failure in cirrhosis
    Puneeta Tandon
    Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
    Semin Liver Dis 28:26-42. 2008
    ..We review the pathogenesis and management of these complications, the role of adrenal insufficiency, and the utility of intensive care prognostic models...
  16. ncbi request reprint Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes
    Finlay A McAlister
    Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Canada
    Diabetes Care 26:1518-24. 2003
    ..To determine the adequacy of perioperative glycemic control in diabetic patients undergoing coronary artery bypass grafting (CABG) and to explore the association between glycemic control and in-hospital morbidity/mortality...
  17. doi request reprint Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices
    J Cheung
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada
    Aliment Pharmacol Ther 30:577-88. 2009
    ..Variable methods are available for secondary prevention after oesophageal variceal bleeding (EVB)...
  18. doi request reprint Managing the post-liver transplantation anastomotic biliary stricture: multiple plastic versus metal stents: a systematic review
    Dina Kao
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Gastrointest Endosc 77:679-91. 2013
    ..Covered self-expandable metal stents (SEMSs) have been increasingly used in this setting. However, it is not clear whether there are definite advantages of using SEMSs over MPSs...
  19. ncbi request reprint The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes
    Puneeta Tandon
    Division of General Internal Medicine, University of Alberta, Edmonton, Canada
    Arch Intern Med 164:769-74. 2004
    ..Little is known about the dosing, tolerability, and impact of beta-blockers in nontrial participants. This study was conducted to evaluate the use and outcomes of beta-blockers in a tertiary care heart failure clinic...
  20. doi request reprint Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management
    Zafrina Poonja
    Division of Gastroenterology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    Clin Gastroenterol Hepatol 12:692-8. 2014
    ..We evaluated how frequently these patients received appropriate and palliative care...
  21. ncbi request reprint The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus
    Puneeta Tandon
    Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
    Am J Gastroenterol 102:1528-36. 2007
    ..The objective of this review was to evaluate the efficacy and safety of rifampin, opioid antagonists, or bile acid binding agents in the treatment of cholestasis-related pruritus (CAP) from available randomized controlled trial evidence...
  22. ncbi request reprint Use of angiotensin-converting enzyme inhibitors after coronary artery bypass grafting in patients with diabetes mellitus
    Lana Bistritz
    Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Canada
    Am J Cardiol 92:77-9. 2003